Noninvasive Prenatal Diagnostics Market
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Noninvasive Prenatal Diagnostics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Services
1.2.3 Instrument
1.3 Market by Application
1.3.1 Global Noninvasive Prenatal Diagnostics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Personal
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Noninvasive Prenatal Diagnostics Market Perspective (2017-2028)
2.2 Noninvasive Prenatal Diagnostics Growth Trends by Region
2.2.1 Noninvasive Prenatal Diagnostics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Noninvasive Prenatal Diagnostics Historic Market Size by Region (2017-2022)
2.2.3 Noninvasive Prenatal Diagnostics Forecasted Market Size by Region (2023-2028)
2.3 Noninvasive Prenatal Diagnostics Market Dynamics
2.3.1 Noninvasive Prenatal Diagnostics Industry Trends
2.3.2 Noninvasive Prenatal Diagnostics Market Drivers
2.3.3 Noninvasive Prenatal Diagnostics Market Challenges
2.3.4 Noninvasive Prenatal Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Noninvasive Prenatal Diagnostics Players by Revenue
3.1.1 Global Top Noninvasive Prenatal Diagnostics Players by Revenue (2017-2022)
3.1.2 Global Noninvasive Prenatal Diagnostics Revenue Market Share by Players (2017-2022)
3.2 Global Noninvasive Prenatal Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Noninvasive Prenatal Diagnostics Revenue
3.4 Global Noninvasive Prenatal Diagnostics Market Concentration Ratio
3.4.1 Global Noninvasive Prenatal Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Noninvasive Prenatal Diagnostics Revenue in 2021
3.5 Noninvasive Prenatal Diagnostics Key Players Head office and Area Served
3.6 Key Players Noninvasive Prenatal Diagnostics Product Solution and Service
3.7 Date of Enter into Noninvasive Prenatal Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Noninvasive Prenatal Diagnostics Breakdown Data by Type
4.1 Global Noninvasive Prenatal Diagnostics Historic Market Size by Type (2017-2022)
4.2 Global Noninvasive Prenatal Diagnostics Forecasted Market Size by Type (2023-2028)
5 Noninvasive Prenatal Diagnostics Breakdown Data by Application
5.1 Global Noninvasive Prenatal Diagnostics Historic Market Size by Application (2017-2022)
5.2 Global Noninvasive Prenatal Diagnostics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Noninvasive Prenatal Diagnostics Market Size (2017-2028)
6.2 North America Noninvasive Prenatal Diagnostics Market Size by Type
6.2.1 North America Noninvasive Prenatal Diagnostics Market Size by Type (2017-2022)
6.2.2 North America Noninvasive Prenatal Diagnostics Market Size by Type (2023-2028)
6.2.3 North America Noninvasive Prenatal Diagnostics Market Share by Type (2017-2028)
6.3 North America Noninvasive Prenatal Diagnostics Market Size by Application
6.3.1 North America Noninvasive Prenatal Diagnostics Market Size by Application (2017-2022)
6.3.2 North America Noninvasive Prenatal Diagnostics Market Size by Application (2023-2028)
6.3.3 North America Noninvasive Prenatal Diagnostics Market Share by Application (2017-2028)
6.4 North America Noninvasive Prenatal Diagnostics Market Size by Country
6.4.1 North America Noninvasive Prenatal Diagnostics Market Size by Country (2017-2022)
6.4.2 North America Noninvasive Prenatal Diagnostics Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Noninvasive Prenatal Diagnostics Market Size (2017-2028)
7.2 Europe Noninvasive Prenatal Diagnostics Market Size by Type
7.2.1 Europe Noninvasive Prenatal Diagnostics Market Size by Type (2017-2022)
7.2.2 Europe Noninvasive Prenatal Diagnostics Market Size by Type (2023-2028)
7.2.3 Europe Noninvasive Prenatal Diagnostics Market Share by Type (2017-2028)
7.3 Europe Noninvasive Prenatal Diagnostics Market Size by Application
7.3.1 Europe Noninvasive Prenatal Diagnostics Market Size by Application (2017-2022)
7.3.2 Europe Noninvasive Prenatal Diagnostics Market Size by Application (2023-2028)
7.3.3 Europe Noninvasive Prenatal Diagnostics Market Share by Application (2017-2028)
7.4 Europe Noninvasive Prenatal Diagnostics Market Size by Country
7.4.1 Europe Noninvasive Prenatal Diagnostics Market Size by Country (2017-2022)
7.4.2 Europe Noninvasive Prenatal Diagnostics Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Noninvasive Prenatal Diagnostics Market Size (2017-2028)
8.2 Asia-Pacific Noninvasive Prenatal Diagnostics Market Size by Type
8.2.1 Asia-Pacific Noninvasive Prenatal Diagnostics Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Noninvasive Prenatal Diagnostics Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Noninvasive Prenatal Diagnostics Market Share by Type (2017-2028)
8.3 Asia-Pacific Noninvasive Prenatal Diagnostics Market Size by Application
8.3.1 Asia-Pacific Noninvasive Prenatal Diagnostics Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Noninvasive Prenatal Diagnostics Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Noninvasive Prenatal Diagnostics Market Share by Application (2017-2028)
8.4 Asia-Pacific Noninvasive Prenatal Diagnostics Market Size by Region
8.4.1 Asia-Pacific Noninvasive Prenatal Diagnostics Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Noninvasive Prenatal Diagnostics Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Noninvasive Prenatal Diagnostics Market Size (2017-2028)
9.2 Latin America Noninvasive Prenatal Diagnostics Market Size by Type
9.2.1 Latin America Noninvasive Prenatal Diagnostics Market Size by Type (2017-2022)
9.2.2 Latin America Noninvasive Prenatal Diagnostics Market Size by Type (2023-2028)
9.2.3 Latin America Noninvasive Prenatal Diagnostics Market Share by Type (2017-2028)
9.3 Latin America Noninvasive Prenatal Diagnostics Market Size by Application
9.3.1 Latin America Noninvasive Prenatal Diagnostics Market Size by Application (2017-2022)
9.3.2 Latin America Noninvasive Prenatal Diagnostics Market Size by Application (2023-2028)
9.3.3 Latin America Noninvasive Prenatal Diagnostics Market Share by Application (2017-2028)
9.4 Latin America Noninvasive Prenatal Diagnostics Market Size by Country
9.4.1 Latin America Noninvasive Prenatal Diagnostics Market Size by Country (2017-2022)
9.4.2 Latin America Noninvasive Prenatal Diagnostics Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Noninvasive Prenatal Diagnostics Market Size (2017-2028)
10.2 Middle East & Africa Noninvasive Prenatal Diagnostics Market Size by Type
10.2.1 Middle East & Africa Noninvasive Prenatal Diagnostics Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Noninvasive Prenatal Diagnostics Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Noninvasive Prenatal Diagnostics Market Share by Type (2017-2028)
10.3 Middle East & Africa Noninvasive Prenatal Diagnostics Market Size by Application
10.3.1 Middle East & Africa Noninvasive Prenatal Diagnostics Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Noninvasive Prenatal Diagnostics Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Noninvasive Prenatal Diagnostics Market Share by Application (2017-2028)
10.4 Middle East & Africa Noninvasive Prenatal Diagnostics Market Size by Country
10.4.1 Middle East & Africa Noninvasive Prenatal Diagnostics Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Noninvasive Prenatal Diagnostics Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Natera
11.1.1 Natera Company Details
11.1.2 Natera Business Overview
11.1.3 Natera Noninvasive Prenatal Diagnostics Introduction
11.1.4 Natera Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022)
11.1.5 Natera Recent Developments
11.2 Illumina
11.2.1 Illumina Company Details
11.2.2 Illumina Business Overview
11.2.3 Illumina Noninvasive Prenatal Diagnostics Introduction
11.2.4 Illumina Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022)
11.2.5 Illumina Recent Developments
11.3 BGI Diagnosis
11.3.1 BGI Diagnosis Company Details
11.3.2 BGI Diagnosis Business Overview
11.3.3 BGI Diagnosis Noninvasive Prenatal Diagnostics Introduction
11.3.4 BGI Diagnosis Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022)
11.3.5 BGI Diagnosis Recent Developments
11.4 Ariosa Diagnostics
11.4.1 Ariosa Diagnostics Company Details
11.4.2 Ariosa Diagnostics Business Overview
11.4.3 Ariosa Diagnostics Noninvasive Prenatal Diagnostics Introduction
11.4.4 Ariosa Diagnostics Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022)
11.4.5 Ariosa Diagnostics Recent Developments
11.5 Quest Diagnostics
11.5.1 Quest Diagnostics Company Details
11.5.2 Quest Diagnostics Business Overview
11.5.3 Quest Diagnostics Noninvasive Prenatal Diagnostics Introduction
11.5.4 Quest Diagnostics Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022)
11.5.5 Quest Diagnostics Recent Developments
11.6 Premaitha Health
11.6.1 Premaitha Health Company Details
11.6.2 Premaitha Health Business Overview
11.6.3 Premaitha Health Noninvasive Prenatal Diagnostics Introduction
11.6.4 Premaitha Health Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022)
11.6.5 Premaitha Health Recent Developments
11.7 NIPD Genetics
11.7.1 NIPD Genetics Company Details
11.7.2 NIPD Genetics Business Overview
11.7.3 NIPD Genetics Noninvasive Prenatal Diagnostics Introduction
11.7.4 NIPD Genetics Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022)
11.7.5 NIPD Genetics Recent Developments
11.8 Labcorp
11.8.1 Labcorp Company Details
11.8.2 Labcorp Business Overview
11.8.3 Labcorp Noninvasive Prenatal Diagnostics Introduction
11.8.4 Labcorp Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022)
11.8.5 Labcorp Recent Developments
11.9 Ravgen
11.9.1 Ravgen Company Details
11.9.2 Ravgen Business Overview
11.9.3 Ravgen Noninvasive Prenatal Diagnostics Introduction
11.9.4 Ravgen Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022)
11.9.5 Ravgen Recent Developments
11.10 LifeCodexx
11.10.1 LifeCodexx Company Details
11.10.2 LifeCodexx Business Overview
11.10.3 LifeCodexx Noninvasive Prenatal Diagnostics Introduction
11.10.4 LifeCodexx Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022)
11.10.5 LifeCodexx Recent Developments
11.11 TrovaGene
11.11.1 TrovaGene Company Details
11.11.2 TrovaGene Business Overview
11.11.3 TrovaGene Noninvasive Prenatal Diagnostics Introduction
11.11.4 TrovaGene Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022)
11.11.5 TrovaGene Recent Developments
11.12 Quest Diagnostics
11.12.1 Quest Diagnostics Company Details
11.12.2 Quest Diagnostics Business Overview
11.12.3 Quest Diagnostics Noninvasive Prenatal Diagnostics Introduction
11.12.4 Quest Diagnostics Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022)
11.12.5 Quest Diagnostics Recent Developments
11.13 Berry Genomics
11.13.1 Berry Genomics Company Details
11.13.2 Berry Genomics Business Overview
11.13.3 Berry Genomics Noninvasive Prenatal Diagnostics Introduction
11.13.4 Berry Genomics Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022)
11.13.5 Berry Genomics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Noninvasive Prenatal Diagnostics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Services
Table 3. Key Players of Instrument
Table 4. Global Noninvasive Prenatal Diagnostics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Noninvasive Prenatal Diagnostics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Noninvasive Prenatal Diagnostics Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Noninvasive Prenatal Diagnostics Market Share by Region (2017-2022)
Table 8. Global Noninvasive Prenatal Diagnostics Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Noninvasive Prenatal Diagnostics Market Share by Region (2023-2028)
Table 10. Noninvasive Prenatal Diagnostics Market Trends
Table 11. Noninvasive Prenatal Diagnostics Market Drivers
Table 12. Noninvasive Prenatal Diagnostics Market Challenges
Table 13. Noninvasive Prenatal Diagnostics Market Restraints
Table 14. Global Noninvasive Prenatal Diagnostics Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Noninvasive Prenatal Diagnostics Revenue Share by Players (2017-2022)
Table 16. Global Top Noninvasive Prenatal Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Noninvasive Prenatal Diagnostics as of 2021)
Table 17. Ranking of Global Top Noninvasive Prenatal Diagnostics Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Noninvasive Prenatal Diagnostics Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Noninvasive Prenatal Diagnostics Product Solution and Service
Table 21. Date of Enter into Noninvasive Prenatal Diagnostics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Noninvasive Prenatal Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Noninvasive Prenatal Diagnostics Revenue Market Share by Type (2017-2022)
Table 25. Global Noninvasive Prenatal Diagnostics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Noninvasive Prenatal Diagnostics Revenue Market Share by Type (2023-2028)
Table 27. Global Noninvasive Prenatal Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Noninvasive Prenatal Diagnostics Revenue Share by Application (2017-2022)
Table 29. Global Noninvasive Prenatal Diagnostics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Noninvasive Prenatal Diagnostics Revenue Share by Application (2023-2028)
Table 31. North America Noninvasive Prenatal Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Noninvasive Prenatal Diagnostics Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Noninvasive Prenatal Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Noninvasive Prenatal Diagnostics Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Noninvasive Prenatal Diagnostics Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Noninvasive Prenatal Diagnostics Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Noninvasive Prenatal Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Noninvasive Prenatal Diagnostics Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Noninvasive Prenatal Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Noninvasive Prenatal Diagnostics Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Noninvasive Prenatal Diagnostics Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Noninvasive Prenatal Diagnostics Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Noninvasive Prenatal Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Noninvasive Prenatal Diagnostics Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Noninvasive Prenatal Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Noninvasive Prenatal Diagnostics Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Noninvasive Prenatal Diagnostics Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Noninvasive Prenatal Diagnostics Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Noninvasive Prenatal Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Noninvasive Prenatal Diagnostics Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Noninvasive Prenatal Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Noninvasive Prenatal Diagnostics Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Noninvasive Prenatal Diagnostics Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Noninvasive Prenatal Diagnostics Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Noninvasive Prenatal Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Noninvasive Prenatal Diagnostics Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Noninvasive Prenatal Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Noninvasive Prenatal Diagnostics Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Noninvasive Prenatal Diagnostics Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Noninvasive Prenatal Diagnostics Market Size by Country (2023-2028) & (US$ Million)
Table 61. Natera Company Details
Table 62. Natera Business Overview
Table 63. Natera Noninvasive Prenatal Diagnostics Product
Table 64. Natera Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022) & (US$ Million)
Table 65. Natera Recent Developments
Table 66. Illumina Company Details
Table 67. Illumina Business Overview
Table 68. Illumina Noninvasive Prenatal Diagnostics Product
Table 69. Illumina Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022) & (US$ Million)
Table 70. Illumina Recent Developments
Table 71. BGI Diagnosis Company Details
Table 72. BGI Diagnosis Business Overview
Table 73. BGI Diagnosis Noninvasive Prenatal Diagnostics Product
Table 74. BGI Diagnosis Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022) & (US$ Million)
Table 75. BGI Diagnosis Recent Developments
Table 76. Ariosa Diagnostics Company Details
Table 77. Ariosa Diagnostics Business Overview
Table 78. Ariosa Diagnostics Noninvasive Prenatal Diagnostics Product
Table 79. Ariosa Diagnostics Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022) & (US$ Million)
Table 80. Ariosa Diagnostics Recent Developments
Table 81. Quest Diagnostics Company Details
Table 82. Quest Diagnostics Business Overview
Table 83. Quest Diagnostics Noninvasive Prenatal Diagnostics Product
Table 84. Quest Diagnostics Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022) & (US$ Million)
Table 85. Quest Diagnostics Recent Developments
Table 86. Premaitha Health Company Details
Table 87. Premaitha Health Business Overview
Table 88. Premaitha Health Noninvasive Prenatal Diagnostics Product
Table 89. Premaitha Health Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022) & (US$ Million)
Table 90. Premaitha Health Recent Developments
Table 91. NIPD Genetics Company Details
Table 92. NIPD Genetics Business Overview
Table 93. NIPD Genetics Noninvasive Prenatal Diagnostics Product
Table 94. NIPD Genetics Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022) & (US$ Million)
Table 95. NIPD Genetics Recent Developments
Table 96. Labcorp Company Details
Table 97. Labcorp Business Overview
Table 98. Labcorp Noninvasive Prenatal Diagnostics Product
Table 99. Labcorp Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022) & (US$ Million)
Table 100. Labcorp Recent Developments
Table 101. Ravgen Company Details
Table 102. Ravgen Business Overview
Table 103. Ravgen Noninvasive Prenatal Diagnostics Product
Table 104. Ravgen Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022) & (US$ Million)
Table 105. Ravgen Recent Developments
Table 106. LifeCodexx Company Details
Table 107. LifeCodexx Business Overview
Table 108. LifeCodexx Noninvasive Prenatal Diagnostics Product
Table 109. LifeCodexx Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022) & (US$ Million)
Table 110. LifeCodexx Recent Developments
Table 111. TrovaGene Company Details
Table 112. TrovaGene Business Overview
Table 113. TrovaGene Noninvasive Prenatal Diagnostics Product
Table 114. TrovaGene Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022) & (US$ Million)
Table 115. TrovaGene Recent Developments
Table 116. Quest Diagnostics Company Details
Table 117. Quest Diagnostics Business Overview
Table 118. Quest Diagnostics Noninvasive Prenatal Diagnostics Product
Table 119. Quest Diagnostics Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022) & (US$ Million)
Table 120. Quest Diagnostics Recent Developments
Table 121. Berry Genomics Company Details
Table 122. Berry Genomics Business Overview
Table 123. Berry Genomics Noninvasive Prenatal Diagnostics Product
Table 124. Berry Genomics Revenue in Noninvasive Prenatal Diagnostics Business (2017-2022) & (US$ Million)
Table 125. Berry Genomics Recent Developments
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Noninvasive Prenatal Diagnostics Market Share by Type: 2021 VS 2028
Figure 2. Services Features
Figure 3. Instrument Features
Figure 4. Global Noninvasive Prenatal Diagnostics Market Share by Application: 2021 VS 2028
Figure 5. Hospital Case Studies
Figure 6. Personal Case Studies
Figure 7. Other Case Studies
Figure 8. Noninvasive Prenatal Diagnostics Report Years Considered
Figure 9. Global Noninvasive Prenatal Diagnostics Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Noninvasive Prenatal Diagnostics Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Noninvasive Prenatal Diagnostics Market Share by Region: 2021 VS 2028
Figure 12. Global Noninvasive Prenatal Diagnostics Market Share by Players in 2021
Figure 13. Global Top Noninvasive Prenatal Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Noninvasive Prenatal Diagnostics as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Noninvasive Prenatal Diagnostics Revenue in 2021
Figure 15. North America Noninvasive Prenatal Diagnostics Market Size YoY (2017-2028) & (US$ Million)
Figure 16. North America Noninvasive Prenatal Diagnostics Market Size Market Share by Type (2017-2028)
Figure 17. North America Noninvasive Prenatal Diagnostics Market Size Market Share by Application (2017-2028)
Figure 18. North America Noninvasive Prenatal Diagnostics Market Size Share by Country (2017-2028)
Figure 19. United States Noninvasive Prenatal Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Noninvasive Prenatal Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Noninvasive Prenatal Diagnostics Market Size YoY (2017-2028) & (US$ Million)
Figure 22. Europe Noninvasive Prenatal Diagnostics Market Size Market Share by Type (2017-2028)
Figure 23. Europe Noninvasive Prenatal Diagnostics Market Size Market Share by Application (2017-2028)
Figure 24. Europe Noninvasive Prenatal Diagnostics Market Size Share by Country (2017-2028)
Figure 25. Germany Noninvasive Prenatal Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France Noninvasive Prenatal Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. Noninvasive Prenatal Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy Noninvasive Prenatal Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia Noninvasive Prenatal Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries Noninvasive Prenatal Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Noninvasive Prenatal Diagnostics Market Size YoY (2017-2028) & (US$ Million)
Figure 32. Asia Pacific Noninvasive Prenatal Diagnostics Market Size Market Share by Type (2017-2028)
Figure 33. Asia Pacific Noninvasive Prenatal Diagnostics Market Size Market Share by Application (2017-2028)
Figure 34. Asia Pacific Noninvasive Prenatal Diagnostics Market Size Share by Region (2017-2028)
Figure 35. China Noninvasive Prenatal Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Japan Noninvasive Prenatal Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. South Korea Noninvasive Prenatal Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Southeast Asia Noninvasive Prenatal Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. India Noninvasive Prenatal Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Australia Noninvasive Prenatal Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 41. Latin America Noninvasive Prenatal Diagnostics Market Size YoY (2017-2028) & (US$ Million)
Figure 42. Latin America Noninvasive Prenatal Diagnostics Market Size Market Share by Type (2017-2028)
Figure 43. Latin America Noninvasive Prenatal Diagnostics Market Size Market Share by Application (2017-2028)
Figure 44. Latin America Noninvasive Prenatal Diagnostics Market Size Share by Country (2017-2028)
Figure 45. Mexico Noninvasive Prenatal Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Brazil Noninvasive Prenatal Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Middle East & Africa Noninvasive Prenatal Diagnostics Market Size YoY (2017-2028) & (US$ Million)
Figure 48. Middle East and Africa Noninvasive Prenatal Diagnostics Market Size Market Share by Type (2017-2028)
Figure 49. Middle East and Africa Noninvasive Prenatal Diagnostics Market Size Market Share by Application (2017-2028)
Figure 50. Middle East and Africa Noninvasive Prenatal Diagnostics Market Size Share by Country (2017-2028)
Figure 51. Turkey Noninvasive Prenatal Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Saudi Arabia Noninvasive Prenatal Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. UAE Noninvasive Prenatal Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Natera Revenue Growth Rate in Noninvasive Prenatal Diagnostics Business (2017-2022)
Figure 55. Illumina Revenue Growth Rate in Noninvasive Prenatal Diagnostics Business (2017-2022)
Figure 56. BGI Diagnosis Revenue Growth Rate in Noninvasive Prenatal Diagnostics Business (2017-2022)
Figure 57. Ariosa Diagnostics Revenue Growth Rate in Noninvasive Prenatal Diagnostics Business (2017-2022)
Figure 58. Quest Diagnostics Revenue Growth Rate in Noninvasive Prenatal Diagnostics Business (2017-2022)
Figure 59. Premaitha Health Revenue Growth Rate in Noninvasive Prenatal Diagnostics Business (2017-2022)
Figure 60. NIPD Genetics Revenue Growth Rate in Noninvasive Prenatal Diagnostics Business (2017-2022)
Figure 61. Labcorp Revenue Growth Rate in Noninvasive Prenatal Diagnostics Business (2017-2022)
Figure 62. Ravgen Revenue Growth Rate in Noninvasive Prenatal Diagnostics Business (2017-2022)
Figure 63. LifeCodexx Revenue Growth Rate in Noninvasive Prenatal Diagnostics Business (2017-2022)
Figure 64. TrovaGene Revenue Growth Rate in Noninvasive Prenatal Diagnostics Business (2017-2022)
Figure 65. Quest Diagnostics Revenue Growth Rate in Noninvasive Prenatal Diagnostics Business (2017-2022)
Figure 66. Berry Genomics Revenue Growth Rate in Noninvasive Prenatal Diagnostics Business (2017-2022)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Industry Market Size
